Technical Analysis for OGEN - Oragenics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.30 | -3.42% | -0.01 |
Earnings due: Nov 7
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Narrow Range Bar | Range Contraction | -3.42% | |
Inside Day | Range Contraction | -3.42% | |
Wide Bands | Range Expansion | -3.42% | |
Lizard Bullish | Bullish Day Trade Setup | -7.07% | |
Doji - Bullish? | Reversal | -7.07% | |
New 52 Week Low | Weakness | -7.07% |
Alert | Time |
---|---|
Down 5% | about 21 hours ago |
60 Minute Opening Range Breakdown | about 22 hours ago |
Down 3% | about 22 hours ago |
Fell Below Previous Day's Low | about 22 hours ago |
Possible NR7 | about 22 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/07/2024
Oragenics, Inc. Description
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Health Care Antibiotics Pet Dog Various Technologies Bacteriology Digestive System Weight Loss Oral Hygiene Probiotics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.74 |
52 Week Low | 0.28 |
Average Volume | 483,934 |
200-Day Moving Average | 1.46 |
50-Day Moving Average | 0.51 |
20-Day Moving Average | 0.33 |
10-Day Moving Average | 0.32 |
Average True Range | 0.05 |
RSI (14) | 33.33 |
ADX | 20.96 |
+DI | 16.60 |
-DI | 26.09 |
Chandelier Exit (Long, 3 ATRs) | 0.31 |
Chandelier Exit (Short, 3 ATRs) | 0.42 |
Upper Bollinger Bands | 0.39 |
Lower Bollinger Band | 0.28 |
Percent B (%b) | 0.16 |
BandWidth | 33.15 |
MACD Line | -0.05 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.0122 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.32 | ||||
Resistance 3 (R3) | 0.32 | 0.32 | 0.32 | ||
Resistance 2 (R2) | 0.32 | 0.31 | 0.32 | 0.32 | |
Resistance 1 (R1) | 0.31 | 0.30 | 0.30 | 0.31 | 0.32 |
Pivot Point | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
Support 1 (S1) | 0.29 | 0.29 | 0.28 | 0.29 | 0.28 |
Support 2 (S2) | 0.28 | 0.29 | 0.28 | 0.28 | |
Support 3 (S3) | 0.27 | 0.28 | 0.27 | ||
Support 4 (S4) | 0.27 |